VEDOLIZUMAB
UNII 9RV78Q2002

Substance Identification & Data

This profile provides standardized clinical and technical data for Vedolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9RV78Q2002.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 943609-66-3 and the RxNorm Concept ID (RxCUI) 1538097. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9RV78Q2002

CAS Registry Number

943609-66-3

RxNorm Concept ID

1538097

Detailed Substance Profile

Preferred Name

VEDOLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

9RV78Q2002

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C95798

National Cancer Institute reference terminology for clinical and research data.

INN ID

9093

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-48

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vedolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VEDOLIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN LPAM-1 (LYMPHOCYTE PEYER'S PATCH ADHESION MOLECULE 1)) (HUMAN-MUS MUSCULUS HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER

VEDOLIZUMAB [INN]

VEDOLIZUMAB [JAN]

VEDOLIZUMAB [MART.]

VEDOLIZUMAB [MI]

VEDOLIZUMAB [PURPLE BOOK CDER]

VEDOLIZUMAB [USAN]

VEDOLIZUMAB [VANDF]

VEDOLIZUMAB [WHO-DD]